-
Symbol
-
KROS on Nasdaq
-
Investment type
-
Equity / Common Stock, $0.0001 par value per share
-
Latest Disclosed Ownership
-
5.39M shares
-
Security Ownership
-
13.3%
Shares, Excluding Options vs Price
Value, Excluding Options
ADAR1 Capital Management, LLC ownership in Keros Therapeutics, Inc. Common Stock, $0.0001 par value per share (KROS)
2025-08-21 - ADAR1 Capital Management, LLC has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 5.39M shares of Keros Therapeutics, Inc. Common Stock, $0.0001 par value per share (KROS).
This represents 13.3% percent ownership of the company.
In their previous filing dated 2025-05-12, ADAR1 Capital Management, LLC had reported owning 5.39M shares, indicating a decrease of -0.03% percent.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.